1. Home
  2. ASMB vs LSBK Comparison

ASMB vs LSBK Comparison

Compare ASMB & LSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • LSBK
  • Stock Information
  • Founded
  • ASMB 2005
  • LSBK 1891
  • Country
  • ASMB United States
  • LSBK United States
  • Employees
  • ASMB N/A
  • LSBK N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • LSBK Savings Institutions
  • Sector
  • ASMB Health Care
  • LSBK Finance
  • Exchange
  • ASMB Nasdaq
  • LSBK Nasdaq
  • Market Cap
  • ASMB 84.5M
  • LSBK 91.1M
  • IPO Year
  • ASMB 2010
  • LSBK 2006
  • Fundamental
  • Price
  • ASMB $13.02
  • LSBK $15.80
  • Analyst Decision
  • ASMB Buy
  • LSBK
  • Analyst Count
  • ASMB 2
  • LSBK 0
  • Target Price
  • ASMB $35.00
  • LSBK N/A
  • AVG Volume (30 Days)
  • ASMB 22.1K
  • LSBK 4.1K
  • Earning Date
  • ASMB 03-27-2025
  • LSBK 01-24-2025
  • Dividend Yield
  • ASMB N/A
  • LSBK 4.56%
  • EPS Growth
  • ASMB N/A
  • LSBK 7.32
  • EPS
  • ASMB N/A
  • LSBK 0.88
  • Revenue
  • ASMB $28,326,000.00
  • LSBK $25,846,000.00
  • Revenue This Year
  • ASMB $282.16
  • LSBK N/A
  • Revenue Next Year
  • ASMB N/A
  • LSBK N/A
  • P/E Ratio
  • ASMB N/A
  • LSBK $17.95
  • Revenue Growth
  • ASMB N/A
  • LSBK N/A
  • 52 Week Low
  • ASMB $11.05
  • LSBK $10.30
  • 52 Week High
  • ASMB $19.93
  • LSBK $16.56
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 40.89
  • LSBK 64.39
  • Support Level
  • ASMB $12.10
  • LSBK $15.51
  • Resistance Level
  • ASMB $14.25
  • LSBK $16.56
  • Average True Range (ATR)
  • ASMB 0.60
  • LSBK 0.42
  • MACD
  • ASMB -0.10
  • LSBK 0.08
  • Stochastic Oscillator
  • ASMB 35.11
  • LSBK 75.95

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About LSBK Lake Shore Bancorp Inc.

Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and, to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.

Share on Social Networks: